Multiple Cancers in a Patient with Systemic Sclerosis and Aggravated Interstitial Lung Disease by Chemotherapy / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
; : 111-115, 2013.
Artículo
en Inglés
| WPRIM (Pacífico Occidental)
| ID: wpr-193684
Biblioteca responsable:
WPRO
ABSTRACT
Although the relationship between malignancy risk with systemic sclerosis (SSc) has been inconclusive, there are some previous studies for a positive correlation. Most patients with SSc have some degree of lung parenchymal involvement in the form of interstitial thickening and fibrosis. Interstitial lung disease is the most common pulmonary manifestation of SSc. Interstitial lung disease following chemotherapy (5-fluorouracil, leucovorin, and oxaliplatin [FOLFOX]) is an uncommon life-threatening complication and it is induced by oxaliplatin. We report a case of multiple cancers in a patient with SSc and aggravated interstitial lung disease by chemotherapy.
Texto completo:
Disponible
Base de datos:
WPRIM (Pacífico Occidental)
Asunto principal:
Compuestos Organoplatinos
/
Esclerodermia Sistémica
/
Fibrosis
/
Leucovorina
/
Enfermedades Pulmonares Intersticiales
/
Pulmón
/
Neoplasias Pulmonares
Límite:
Humanos
Idioma:
Inglés
Revista:
Tuberculosis and Respiratory Diseases
Año:
2013
Tipo del documento:
Artículo